Prion disease: the implications for dentistry

被引:14
作者
Azarpazhoob, Amir [1 ]
Filloy, Edivard D. [2 ]
机构
[1] Univ Toronto, Fac Dent, Dept Endodont, Toronto, ON M5G 1G6, Canada
[2] Univ Toronto, Dept Oral Microbiol, Toronto, ON M5G 1G6, Canada
关键词
dental; dental care; infection control; prion diseases;
D O I
10.1016/j.joen.2008.07.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The aim of this article was to provide the dental community with a brief overview of the characteristics, of transmission, and the infection-control implications of prions in dentistry. MEDLINE, EMBASE, CINAHL, The Cochrane Library, and relevant databases were searched, and a targeted internet search was conducted up to July 2007. Transmissible spongiform encephalopathies (TSEs) are a group of fatal neurodegenerative diseases that are rapidly progressive and always fatal, with no approved cure, and their definite diagnosis can only be obtained at postmortem autopsy. The causative agent, prion protein, resists conventional sterilization methods especially when infected tissue becomes dried onto glass or metal surfaces. To date, there are no reported definite or suspected cases of disease transmission arising from dental procedures, and there seems to be no correlation between dental treatment and TSEs. Because there is a theoretical but real risk of transmission of prion disease from dental instruments (although it is extremely low, especially in North America), as a general rule, appropriate family and medical history (including the risk for prion diseases) should be obtained from all patients, before all dental procedures. TSE research regarding diagnosis, transmission, treatment, and inactivation of prions and other transmissible amyloidoses are ongoing, and, thus, dental professionals should maintain optimal and up-to-date standards of knowledge, infection control, and decontamination.
引用
收藏
页码:1158 / 1166
页数:9
相关论文
共 123 条
  • [1] TRANSMISSION OF AGENT OF CREUTZFELDT-JAKOB DISEASE
    ADAMS, DH
    EDGAR, WM
    [J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6118) : 987 - 987
  • [2] *ADV COMM DANG PAT, 2003, TRANSM SPONG ENC AG
  • [3] Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease
    Alperovitch, A
    Zerr, I
    Pocchiari, M
    Mitrova, E
    Cuesta, JD
    Hegyi, I
    Collins, S
    Kretzschmar, H
    van Duijn, C
    Will, RG
    [J]. LANCET, 1999, 353 (9165) : 1673 - 1674
  • [4] CLUSTERING OF 3 CASES OF CREUTZFELDT-JAKOB DISEASE NEAR FUKUOKA CITY, JAPAN
    ARAKAWA, K
    NAGARA, H
    ITOYAMA, Y
    DOHURA, K
    TOMOKANE, N
    TATEISHI, J
    GOTO, I
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (05): : 445 - 447
  • [5] *AUSTR GOV DEP HLT, 2007, INF CONTR GUID PRE 4
  • [6] Prion diseases: infectious and lethal doses following oral challenge
    Baier, M
    Norley, S
    Schultz, J
    Burwinkel, M
    Schwarz, A
    Riemer, C
    [J]. JOURNAL OF GENERAL VIROLOGY, 2003, 84 : 1927 - 1929
  • [7] Rapid prion neuroinvasion following tongue infection
    Bartz, JC
    Kincaid, AE
    Bessen, RA
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (01) : 583 - 591
  • [8] Bebermeyer RD, 2003, QUINTESSENCE INT, V34, P38
  • [9] Creutzfeldt-Jakob disease surveillance and diagnosis
    Belay, ED
    Holman, RC
    Schonberger, LB
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (06) : 834 - 836
  • [10] Chronic wasting disease and potential transmission to humans
    Belay, ED
    Maddox, RA
    Williams, ES
    Miller, MW
    Gambetti, P
    Schonberger, LB
    [J]. EMERGING INFECTIOUS DISEASES, 2004, 10 (06) : 977 - 984